Application | Comment | Organism |
---|---|---|
pharmacology | the enzyme is a promising therapeutic strategy for cardiovascular disease | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
AUDA | - |
Homo sapiens | |
AUDA-BE | - |
Homo sapiens | |
additional information | sEH inhibitors are developed to enhance the cardiovascular actions of epoxyeicosatrienoic acids, treatment potentials, cardiovascular therapeutic effects, antihypertensive effects, kidney-protective properties, cardiac-protective properties, and protection against ischaemic stroke and vascular disease of sEH inhibitors, overview | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
soluble | - |
Homo sapiens | - |
- |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
(5Z,11Z,14Z)-8,9-epoxyeicosatrienoic acid + H2O | Homo sapiens | - |
(5Z,11Z,14Z)-8,9-dihydroxyeicosatrienoic acid | - |
? | |
(5Z,8Z,11Z)-14,15-epoxyeicosatrienoic acid + H2O | Homo sapiens | - |
(5Z,8Z,11Z)-14,15-dihydroxyeicosatrienoic acid | - |
? | |
(5Z,8Z,14Z)-11,12-epoxyeicosatrienoic acid + H2O | Homo sapiens | - |
(5Z,8Z,14Z)-11,12-dihydroxyeicosatrienoic acid | - |
? | |
(8Z,11Z,14Z)-5,6-epoxyeicosatrienoic acid + H2O | Homo sapiens | - |
(8Z,11Z,14Z)-5,6-dihydroxyeicosatrienoic acid | - |
? | |
additional information | Homo sapiens | Vascular actions and antiinflammatory actions of epoxyeicosatrienoic acids, overview | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P34913 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | - |
Homo sapiens | - |
heart | - |
Homo sapiens | - |
kidney | - |
Homo sapiens | - |
liver | - |
Homo sapiens | - |
lung | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
(5Z,11Z,14Z)-8,9-epoxyeicosatrienoic acid + H2O | - |
Homo sapiens | (5Z,11Z,14Z)-8,9-dihydroxyeicosatrienoic acid | - |
? | |
(5Z,8Z,11Z)-14,15-epoxyeicosatrienoic acid + H2O | - |
Homo sapiens | (5Z,8Z,11Z)-14,15-dihydroxyeicosatrienoic acid | - |
? | |
(5Z,8Z,14Z)-11,12-epoxyeicosatrienoic acid + H2O | - |
Homo sapiens | (5Z,8Z,14Z)-11,12-dihydroxyeicosatrienoic acid | - |
? | |
(8Z,11Z,14Z)-5,6-epoxyeicosatrienoic acid + H2O | - |
Homo sapiens | (8Z,11Z,14Z)-5,6-dihydroxyeicosatrienoic acid | - |
? | |
additional information | Vascular actions and antiinflammatory actions of epoxyeicosatrienoic acids, overview | Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
SEH | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
metabolism | the enzyme is involved in the arachidonate cascade, pathways overview | Homo sapiens |
physiological function | conversion of epoxyeicosatrienoic acids to their corresponding diols, dihydroxyeicosatrienoic acids, DHETS, by sEH is responsible for decreasing EET levels and thereby diminishing their beneficial cardiovascular properties, detailed overview | Homo sapiens |